These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8409046)

  • 1. Use of a regional wall motion score to enhance risk stratification of patients receiving an implantable cardioverter-defibrillator.
    Nath S; DeLacey WA; Haines DE; Berry VA; Barber MJ; Kron IL; DiMarco JP
    J Am Coll Cardiol; 1993 Oct; 22(4):1093-9. PubMed ID: 8409046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the usefulness of the implantable cardioverter-defibrillator and subendocardial resection in patients with sustained ventricular arrhythmias and poor regional wall motion associated with coronary artery disease.
    Nath S; Haines DE; DeLacey WA; Berry VA; Barber MJ; Kron IL; DiMarco JP
    Am J Cardiol; 1993 Sep; 72(9):652-7. PubMed ID: 8249839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.
    Powell AC; Fuchs T; Finkelstein DM; Garan H; Cannom DS; McGovern BA; Kelly E; Vlahakes GJ; Torchiana DF; Ruskin JN
    Circulation; 1993 Sep; 88(3):1083-92. PubMed ID: 8353870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional wall motion analysis predicts survival and functional outcome after subendocardial resection in patients with prior anterior myocardial infarction.
    Nath S; Haines DE; Kron IL; Barber MJ; DiMarco JP
    Circulation; 1993 Jul; 88(1):70-6. PubMed ID: 8319358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart disease.
    Marynissen T; Floré V; Heidbuchel H; Nuyens D; Ector J; Willems R
    Europace; 2014 Jul; 16(7):1069-77. PubMed ID: 24196450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality, left ventricular ejection fraction, and prevalence of new left ventricular wall motion abnormality at long-term follow-up in patients with implantable cardioverter defibrillators treated with biventricular pacing versus right ventricular pacing.
    Sukhija R; Aronow WS; Sorbera C; Peterson SJ; Frishman WH; Cohen M
    Am J Ther; 2007; 14(4):328-30. PubMed ID: 17667205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.
    Mikami Y; Jolly U; Heydari B; Peng M; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Lydell CP; Howarth AG; Yee R; White JA
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28087564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
    Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
    Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Longitudinal Deformation Improves Prediction of Ventricular Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction: A MADIT-CRT Substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
    Biering-Sørensen T; Knappe D; Pouleur AC; Claggett B; Wang PJ; Moss AJ; Solomon SD; Kutyifa V
    Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28003221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic importance of wall motion abnormalities in patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator.
    Mahenthiran J; Das MK; Bhakta D; Ghumman W; Feigenbaum H; Sawada SG
    Am J Cardiol; 2006 Nov; 98(10):1301-6. PubMed ID: 17134618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.
    Barsheshet A; Moss AJ; Huang DT; McNitt S; Zareba W; Goldenberg I
    J Am Coll Cardiol; 2012 Jun; 59(23):2075-9. PubMed ID: 22651863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention.
    Boden H; Ahmed TA; Velders MA; van der Hoeven BL; Hoogslag GE; Bootsma M; le Cessie S; Cobbaert CM; Delgado V; van der Laarse A; Schalij MJ
    Am J Cardiol; 2013 May; 111(10):1387-93. PubMed ID: 23465094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of all-cause mortality in different age groups in patients with severe systolic left ventricular dysfunction receiving an implantable cardioverter defibrillator (from the Italian ClinicalService Multicenter Observational Project).
    Fumagalli S; Gasparini M; Landolina M; Lunati M; Boriani G; Proclemer A; Santini M; Mangoni L; Padeletti M; Marchionni N; Padeletti L;
    Am J Cardiol; 2014 May; 113(10):1691-6. PubMed ID: 24792738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
    Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic stratification of survivors of lst myocardial infarction: evaluation of regional kinetics and ejection fraction by bidimensional echocardiography].
    Catania G; Bruni A; Bridda A; Cargnel G; Sardina G; Soravia G; Carlini A
    G Ital Cardiol; 1990 Feb; 20(2):133-43. PubMed ID: 2328867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.